Via Surgical said today that it raised a $6 million funding round for its FasTouch hernia suture.
Benslie Investment Group led the round, with managing partner Nicolas Weinstein joining Amirim, Israel-based Via Surgical’s board.
“The addition of Benslie Investment Group to our highly experienced team validates the opportunity to advance patient care with the FasTouch deployable suture fixation system. Their investment will greatly support the increasing clinical demand for improved fixation through our development and commercialization efforts in 2016,” co-founder & CFO Lena Levin said in prepared remarks. “FasTouch, a novel fixation technology is the first with the potential to provide a comprehensive fixation solution in hernia repair. The lockable sutures are designed to significantly minimize foreign body material, providing the first and only light-weight hernia fixation system.”
FasTouch is designed to combine the best elements of sutures and tacks, reducing the amount of foreign material left in the body after hernia repair using surgical mesh, according to the company’s website.
“We are very excited to partner with Via Surgical to introduce a novel hernia mesh fastening device with the potential to improve patient outcomes. It is a fantastic device that benefits all stakeholders. Via Surgical is a great addition to our portfolio of healthcare companies with a proven team, top advisory board and late stage technology,” Weinstein added.
Intuitive Surgical enjoyed a nearly two-decade monopoly in the robot-assisted surgery space. At DeviceTalks West, we'll delve into that history as longtime CEO Gary Guthart tells us how he got his start in medtech, how Intuitive came to enjoy such a commanding lead and what the future holds for medical robotics.
Use code GUTHART to save an additional 10%.